Devyser Diagnostics AB (OSTO:DVYSR) Common Stock : kr1.0 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Common Stock?

Devyser Diagnostics AB's quarterly common stock stayed the same from Jun. 2024 (kr0.9 Mil) to Sep. 2024 (kr0.9 Mil) but then increased from Sep. 2024 (kr0.9 Mil) to Dec. 2024 (kr1.0 Mil).

Devyser Diagnostics AB's annual common stock stayed the same from Dec. 2022 (kr0.9 Mil) to Dec. 2023 (kr0.9 Mil) but then increased from Dec. 2023 (kr0.9 Mil) to Dec. 2024 (kr1.0 Mil).

Devyser Diagnostics AB Common Stock Historical Data

The historical data trend for Devyser Diagnostics AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB Common Stock Chart

Devyser Diagnostics AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

0.50

0.87

0.90

1.00

Devyser Diagnostics AB Quarterly Data
	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															0.90	0.90	0.90	0.90	1.00

Devyser Diagnostics AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Devyser Diagnostics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (OSTO:DVYSR) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

OL0:Germany

Address

Instrumentvagen 19, Hagersten, SWE, 126 53

Website

https://www.devyser.com

Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB Headlines

No Headlines